share_log

Stryker Insiders Sell US$153m Of Stock, Possibly Signalling Caution

Stryker Insiders Sell US$153m Of Stock, Possibly Signalling Caution

Stryker 內部人士出售1.53億美元的股票,可能表示謹慎行事
Simply Wall St ·  2023/12/09 09:11

The fact that multiple Stryker Corporation (NYSE:SYK) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. When evaluating insider transactions, knowing whether insiders are buying versus if they selling is usually more beneficial, as the latter can be open to many interpretations. However, when multiple insiders sell stock over a specific duration, shareholders should take notice as that could possibly be a red flag.

在過去的一年中,多位Stryker Corporation(紐約證券交易所代碼:SYK)內部人士拋售了大量股票,這一事實可能會引起投資者的關注。在評估內幕交易時,了解內部人士是買入還是賣出通常更有利,因爲後者可能有多種解釋。但是,當多位內部人士在特定期限內出售股票時,股東應注意,因爲這可能是一個危險信號。

While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.

儘管在長期投資方面,內幕交易並不是最重要的事情,但我們確實認爲密切關注內部人士的所作所爲是完全合乎邏輯的。

View our latest analysis for Stryker

查看我們對 Stryker 的最新分析

Stryker Insider Transactions Over The Last Year

去年 Stryker 的內幕交易

In the last twelve months, the biggest single sale by an insider was when the Independent Director, Ronda Stryker, sold US$142m worth of shares at a price of US$281 per share. That means that an insider was selling shares at slightly below the current price (US$289). As a general rule we consider it to be discouraging when insiders are selling below the current price, because it suggests they were happy with a lower valuation. However, while insider selling is sometimes discouraging, it's only a weak signal. It is worth noting that this sale was only 2.4% of Ronda Stryker's holding.

在過去的十二個月中,內部人士最大的一次出售是獨立董事隆達·斯特雷克以每股281美元的價格出售了價值1.42億美元的股票。這意味着一位內部人士以略低於當前價格(289美元)的價格出售股票。通常,當內部人士以低於當前價格的價格出售時,我們認爲這會令人沮喪,因爲這表明他們對較低的估值感到滿意。但是,儘管內幕拋售有時令人沮喪,但這只是一個微弱的信號。值得注意的是,此次出售僅佔隆達·史賽克持股量的2.4%。

Insiders in Stryker didn't buy any shares in the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

去年,Stryker的內部人士沒有購買任何股票。你可以在下面看到過去 12 個月內幕交易(由公司和個人進行的)的直觀描述。點擊下圖,你可以看到每筆內幕交易的確切細節!

insider-trading-volume
NYSE:SYK Insider Trading Volume December 9th 2023
紐約證券交易所:SYK 內幕交易量 2023 年 12 月 9 日

I will like Stryker better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我看到一些大筆的內幕買入,我會更喜歡Stryker。在我們等待的同時,請查看這份免費名單,列出了最近有大量內幕買入的成長型公司。

Insiders At Stryker Have Sold Stock Recently

Stryker 的內部人士最近出售了股票

The last three months saw significant insider selling at Stryker. In total, insiders dumped US$822k worth of shares in that time, and we didn't record any purchases whatsoever. Overall this makes us a bit cautious, but it's not the be all and end all.

在過去的三個月中,Stryker進行了大量的內幕拋售。在此期間,內部人士總共拋售了價值82.2萬美元的股票,我們沒有記錄任何買入記錄。總的來說,這讓我們有些謹慎,但這並不是萬能的。

Insider Ownership

內部所有權

Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Stryker insiders own 11% of the company, currently worth about US$12b based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

許多投資者喜歡檢查公司有多少股份由內部人士擁有。通常,內部人所有權越高,內部人士被激勵長期建立公司的可能性就越大。Stryker內部人士擁有該公司11%的股份,根據最近的股價,目前價值約爲120億美元。內部人士持有這種重大所有權通常會增加公司爲所有股東的利益而經營的機會。

What Might The Insider Transactions At Stryker Tell Us?

Stryker 的內幕交易可能告訴我們什麼?

Insiders haven't bought Stryker stock in the last three months, but there was some selling. And even if we look at the last year, we didn't see any purchases. But since Stryker is profitable and growing, we're not too worried by this. While insiders do own a lot of shares in the company (which is good), our analysis of their transactions doesn't make us feel confident about the company. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Stryker. Every company has risks, and we've spotted 1 warning sign for Stryker you should know about.

在過去的三個月中,業內人士沒有買入Stryker的股票,但有一些人拋售。而且,即使我們看看去年,我們也沒有看到任何購買。但是,由於Stryker盈利並且正在增長,因此我們對此並不太擔心。儘管內部人士確實擁有該公司的大量股份(這很好),但我們對他們交易的分析並不能使我們對公司充滿信心。除了了解正在進行的內幕交易外,確定Stryker面臨的風險也是有益的。每家公司都有風險,我們發現了 Stryker 的 1 個警告信號,你應該知道。

But note: Stryker may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

但請注意:Stryker可能不是最值得買入的股票。因此,來看看這份免費列出的投資回報率高、債務低的有趣公司的名單。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益,不包括衍生品交易或間接權益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論